Probiotic use in irritable bowel syndrome

Patrick Young*, Brooks D. Cash

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Over the past several years, a number of studies have addressed the role of specific strains of bacteria, or combinations thereof, to alleviate certain symptoms of irritable bowel syndrome (IBS). More importantly, the precise factors that contribute to this therapeutic effect, such as modulations in cytokine levels and alterations in colonic motility, are being clarified. This review serves to summarize the evidence for the use of probiotics in the treatment of IBS and to place this information in clinical context. Potential future developments and areas of possible research are also discussed.

Original languageEnglish
Pages (from-to)321-326
Number of pages6
JournalCurrent Gastroenterology Reports
Volume8
Issue number4
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Probiotic use in irritable bowel syndrome'. Together they form a unique fingerprint.

Cite this